AprilBio Co.,Ltd. (KOSDAQ: 397030)

Market Cap	337.88B
Revenue	n/a
Net Income	n/a
Shares Out	22.44M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	238,066
Open	16,000
Previous Close	16,600
Day's Range	15,580 - 16,150
52-Week Range	11,500 - 25,900
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About AprilBio Co.,Ltd.

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 397030